TRx Biosciences

TRx Biosciences is a biotechnology company. Its technology employs clinically and developmentally validated methods to deliver targeted oral medications to specific organs, cells, and tissues affected by cancer, central nervous system disorders, respiratory diseases, and immune system conditions. Breakthrough advancements in oral drug absorption enable the direct delivery of therapeutic agents to the site of disease, reducing the impact of first-pass metabolism and enhancing the production of regulatory immune cells.